Stay updated with breaking news from Antibody Engineering Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Record revenue of $203.6 million in Fiscal 2022; Increase of 54% over $132.3 million in Fiscal 2021 – -- Orders increased to $226 million in Fiscal 2022; Increase of 42% over $160 million... | November 18, 2022
CAMBRIDGE, Mass., Nov. 15, 2022 /PRNewswire/ -- Nona Biosciences (a wholly-owned subsidiary of HBM Holdings, HKEX: 02142) announced that the Company is attending the 14th Protein and Antibody
Data showing greater glycosylation homogeneity with the FastPharming system was presented at PEGS Boston 2022